BECLOMETHASONE DIPROPIONATE
| Brand name | QVAR REDIHALER |
|---|---|
| Active ingredient | BECLOMETHASONE DIPROPIONATE |
| Strength | 0.04MG/INH |
| Dosage form | AEROSOL, METERED |
| Route | INHALATION |
| Modality | Small molecule |
| FDA approval | August 2017 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11583643 | August 2041 | product |
| 11957832 | May 2041 | product |
| 11559637 | July 2039 | product |
| 10792447 | January 2039 | product |
| 11793953 | January 2038 | product |
| 12296089 | January 2038 | product |
| 11395888 | January 2038 | product |
| 10561808 | January 2032 | product |
| 8931476 | July 2031 | product |
| 10022509 | May 2031 | product |
| 10086156 | May 2031 | product |
| 10695512 | May 2031 | product |
| 10022510 | May 2031 | product |
| 11395889 | May 2031 | product |
| 8132712 | September 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.